Happy Thanksgiving from all of us at Lexitas! 🦃
Lexitas Pharma Services
Research Services
Durham, North Carolina 15,191 followers
More than a CRO: Your Partner for Unmatched Expertise and Precision in Ophthalmology Research
About us
Lexitas is a clinical research organization dedicated exclusively to ophthalmology since 2011. With unmatched expertise and precision in ophthalmic research, we deliver tailored approaches, rigorous quality standards, and unwavering commitment to operational success. Our dedicated team of ophthalmic experts guides each study with deep scientific and clinical experience, offering customized solutions to meet your needs at every stage of development. We have extensive experience in posterior and anterior segments, as well as rare diseases. Service Offerings: -Regulatory strategy -Study design and protocol development -Endpoint evaluation and selection -Site selection, management and training -Clinical project management and monitoring -Medical monitoring -Data management & Biostatistics -Reading center -Medical Affairs & commercialization strategies
- Website
-
http://www.lexitas.com/
External link for Lexitas Pharma Services
- Industry
- Research Services
- Company size
- 51-200 employees
- Headquarters
- Durham, North Carolina
- Type
- Privately Held
- Founded
- 2011
- Specialties
- CRO, Pharmaceutical Research Services, Ophthalmology, Medical Device Research Services, and Clinical Trial Services
Locations
-
Primary
Get directions
5425 Page Rd
Suite 410
Durham, North Carolina 27703, US
Employees at Lexitas Pharma Services
-
Billy Seawell
Senior Finance Professional | Transforming Business Operations Through Revenue Strategy, Financial Management, and Data-Driven Leadership
-
Joseph Boorady
Serial Entrepreneur I Independent Board Director l Global CEO l Investor l M&A l Medical Devices l Biotech l Private Equity I Business Development
-
Katie (Romans) Thorson
Sr. Director of Clinical Data Management at Lexitas Pharma Services
-
Andy Lipetz
Commercial Operations @ Lexitas
Updates
-
New episodes of The Retina Radar out this week! Lexitas Advisory Board member, Arshad M. Khanani, discusses emerging therapeutics, biosimilars, and gene therapies for retinal diseases with other experts. Click below to listen ⬇️
Please check out these new episodes! I had the pleasure of hosting my brilliant colleagues Christine Kay, Ashish Sharma, Dante Pieramici, and Robert Avery on the latest recordings of Retina Radar podcast. These episodes have further fueled my enthusiasm about the advances unfolding in the treatment of IRDs, the progress making gene therapy for common retinal diseases a practical reality that could reduce treatment burden, and the growing role of biosimilars in expanding access to care worldwide. Please see the links below: Episode 10 - " The Retina Radar With Dr. Arshad Khanani: Emerging Therapeutics for Rare Retinal Diseases With Dr. Christina Kay: https://lnkd.in/giG3beQZ. Episode 11 - "The Retina Radar With Dr. Arshad Khanani: Biosimilars for Retinal Diseases With Dr. Ashish Sharma,": https://lnkd.in/gZRFtw2A. Episode 12 - "The Retina Radar With Dr. Arshad Khanani: Gene Therapy in 2025 With Drs. Avery and Pieramici,": https://lnkd.in/gdqVkNnC. Stay tuned for more episodes launching before the end of the year!! Enjoy!! #RetinaRadar #ClinicalTrials #IRDs #GeneTherapy #Biosimilars Vindico Medical Education Sasha Persaud Zora H. Robert Esgro Jenna Gentile Simon Cooper Kelly Cogan
-
-
Click below to check out our Q4 edition of Visionary Insights! This quarter, we're highlighting the latest innovations in retina research, news from our team, upcoming events, and an overview of the ophthalmic investment landscape. Subscribe today to see Visionary Insights a week early and delivered straight to your inbox each quarter➡️ https://lnkd.in/ecfkp3gn #VisionaryInsights #newsletter #ophthalmology #industry
-
We're excited to share that our CEO & Chairwoman, Jeanne Hecht, was recently selected for Marquis Who's Who! Honorees are chosen based on factors such as noteworthy accomplishments, visibility, and prominence in their field. Jeanne has more than three decades of experience in the life sciences space, serving as a leader, mentor, investor, advisor, and more. Her knowledge and expertise in the clinical industry are an invaluable asset to our team and partners. Congratulations on this well-deserved achievement, Jeanne! Click to view the full press release➡️ https://hubs.li/Q03VhY0W0
-
-
Last week, our Chief Medical Officer, David J. Tanzer, MD, had the opportunity to visit Sierra Eye Associates and spend the day with our Industry, Medical, and Scientific Advisory Board member, Dr. Arshad M. Khanani, learning more about his practice and patients. While there, he also bumped into one of our Study Coordinator Advisory Board Members, Rogina Mojumder! That's a good-looking sweatshirt, if we do say so ourselves.😉 #retina #lexitas #ophthalmology
-
-
OIS Ignite is happening today! Be sure to check out this afternoon's panel, "Trial by Fire: What Early-Stage Teams Really Need from Their CROs", featuring our CMO, David J. Tanzer, MD!
Senior Healthcare-Medical Leadership: Chief Medical Officer | Board Member | Clinical Development & Medical Affairs Expert | Deep Anterior & Posterior Segment Ophthalmology Exp. | Career Record of Exceptional Results
Very excited to be at OIS Ignite today! Looking forward to this afternoon's panel moderated by @Barbara Wirostko, and to some great conversations over the next few days.
-
-
We are excited to share that Lexitas team members recently completed on-time final database locks for a blepharitis study AND a dry eye study! 🎉 Thank you to the many Lexitans who worked on these projects and made this achievement possible. If you are looking for a clinical research partner for your upcoming ophthalmology study, reach out to our team today ➡️ https://hubs.li/Q03V7D3v0 #ClinicalResearch #ClinicalOperations #Blepharitis #DryEye
-
-
This week, some of our awesome CRAs are in Durham at Lexitas HQ to complete their BCVA training through our in-house BCVA certification program! Our Senior Director of Clinical and Medical Affairs, Nevin El- Nimri OD, MS, PhD, FAAO, is also on-site to facilitate these trainings. Local team members, including our CEO, Jeanne Hecht, have volunteered throughout this week to help the CRAs practice refractions. Lexitas' BCVA Certification Program was developed by experts and tested by real sites to reduce variability in clinical trials. Download our one-pager to learn more about this unique offering: https://hubs.li/Q03TS7650 #BCVA #CRO #clinicalresearch
-
-
Lexitas Pharma Services reposted this
CEO, NED, Board Member & Chair | Strategist | 2025 TBJ CEO of the Year winner | Dedicated to helping change the way people see the world.
A great morning engaging in conversations about advancing healthcare and clinical research in an ever-changing world. #unckfsb #tarheel Lexitas Pharma Services
-
-
Only 1 week left until OIS festivities kick off in San Diego! ☀️ Our Chief Medical Officer, David J. Tanzer, MD will join the panel, "Trial by Fire: What Early-Stage Teams Really Need from Their CROs" during OIS Ignite on November 20th. David and other industry leaders, including Lexitas Industry, Medical and Scientific Advisory Board member Claire M. Gelfman, will discuss everything from preclinical planning to regulatory standards. On November 21-22, BD Director Dre Long will join David for OIS XV! Click below to request a meeting with our team ⬇️ https://hubs.li/Q03T3v5j0 Ophthalmology Innovation Source #OISXV #OISIgnite
-